Komori
Fuji Pharma (4554) · InitiativeFirst stated

Completion of the Solid Dosage Form Pilot Plant at the Toyama R&D Center and Consolidation of Equipment

First written in FY2018. . Latest entry: FY2018.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Completion of Toyama R&D Center solid dosage form pilot production building and equipment consolidationA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2018First statedAnnual report

    「In July 2018, we completed a new solid dosage form pilot plant, consolidated solid dosage form manufacturing equipment that had previously been dispersed at the Toyama Research and Development Center, improved operational and management efficiency, and advanced the development of pharmaceuticals containing various active ingredients.」

    For the first time, specifically describes the completion of the solid dosage form pilot plant in July 2018, the consolidation of manufacturing equipment at the Research and Development Center, and improvements in operational and management efficiency.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Completion of the Solid Dosage Form Pilot Plant at the Toyama R&D Center and Consolidation of Equipment | Fuji Pharma Co.,Ltd. (4554) | Komori